Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
US5182107A · kind A · utility
105Cited by
9References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 6, 1992 |
| Grant date | Jan 26, 1993 |
| Priority date | — |
| Expiry date | Mar 6, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains to a method for delivering a neuropharmaceutical or diagnostic agent across the blood brain barrier to the brain of a host. The method comprises administering to the host a therapeutically effective amount of an antibody-neuropharmaceutical or diagnostic agent conjugate wherein the antibody is reactive with a transferrin receptor. Other aspects of this invention include a delivery system comprising an antibody reactive with a transferrin receptor linked to a neuropharmaceutical or diagnostic agent and methods for treating hosts afflicted with a disease associated with a neurological disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.